$18.00
1.458.76%
Last update: Oct 26, 3:18 PM
DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. (DSKYF) Stock Price, Quote, News & History
DSKYFOTCPK
FDA grants accelerated approval to AstraZeneca's Datroway for EGFR-mutant NSCLC after prior therapies, with a 45% response rate and a $45 million milestone due.
You can purchase shares of DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. (OTCPK:DSKYF) through any online brokerage.
There are no as such competitors for DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd..
There is no analysis for DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. to provide a consensus price target.
The stock price for DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. (OTCPK: DSKYF) is $18 last updated October 26, 2026 at 3:18 PM EDT.
There are no upcoming dividends for DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd..
DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. does not have any upcoming earnings scheduled.
There is no upcoming split for DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd..
DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2024, approximately one quarter of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint....
